⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27524215 | 0.97 | TSHR (0.48) | — | |
| SCHEMBL533383 | 0.84 | TSHR (0.42) | — | |
| SCHEMBL7691395 | 0.77 | — | — | |
| SCHEMBL27674462 | 0.77 | — | — | |
| SCHEMBL22363110 | 0.77 | — | — | |
| SCHEMBL9529187 | 0.77 | — | — | |
| SCHEMBL11206282 | 0.77 | — | — | |
| SCHEMBL5075045 | 0.75 | TSHR (0.67) | — | |
| SCHEMBL3121541 | 0.75 | LMNA (0.32) | — | |
| SCHEMBL5249727 | 0.73 | SLC6A2 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 193 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107022082-A | A kind of application of silicon substrate hyperbranched conjugated polymer in Nitro-aromatic Compounds in Different detection | 齐鲁工业大学 | 2017-08-08 | — | — | CN | claimed |
| CN-107022083-A | A kind of silicon substrate hyperbranched conjugated polymer and preparation method thereof | 齐鲁工业大学 | 2017-08-08 | — | — | CN | claimed |
| EP-2415763-B1 | PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING GLAUCOMA | UBE INDUSTRIES (JP) | 2016-01-27 | — | — | EP | claimed |
| US-20140113907-A1 | PYRIDYLAMINOACETIC ACID COMPOUND | UBE INDUSTRIES, LTD. (JP) | 2014-04-24 | — | — | US | claimed |
| EP-2520570-A1 | AMINOPYRIDINE COMPOUND | Ube Industries, Ltd. (JP) | 2012-11-07 | — | — | EP | claimed |
| US-20120259123-A1 | AMINOPYRIDINE COMPOUND | UBE INDUSTRIES, LTD. (JP) | 2012-10-11 | — | — | US | claimed |
| CN-102666490-A | Aminopyridine compound | UBE INDUSTRIES | 2012-09-12 | — | — | CN | claimed |
| US-20120190852-A1 | MEDICAL COMPOSITION FOR TREATMENT OR PROPHYLAXIS OF GLAUCOMA | UBE INDUSTRIES, LTD. (JP) | 2012-07-26 | — | — | US | claimed |
| CN-102448940-A | Pharmaceutical composition for treating or preventing glaucoma | UBE INDUSTRIES | 2012-05-09 | — | — | CN | claimed |
| EP-2415763-A1 | PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING GLAUCOMA | Ube Industries, Ltd. (JP) | 2012-02-08 | — | — | EP | claimed |
| US-20110054172-A1 | PYRIDYLAMINOACETIC ACID COMPOUND | UBE CORPORATION (JP) | 2011-03-03 | — | — | US | claimed |
| CN-101970410-A | Pyridylaminoacetic acid compounds | UBE INDUSTRIES | 2011-02-09 | — | — | CN | claimed |
| EP-2264009-A1 | PYRIDYLAMINOACETIC ACID COMPOUND | Ube Industries, Ltd. (JP) | 2010-12-22 | — | — | EP | claimed |
| EP-1653960-A4 | MELANIN CONCENTRATING HORMONE RECEPTOR ANTAGONIST | AMGEN INC (US) | 2008-11-26 | — | — | EP | claimed |
| EP-1899339-A1 | 1,2-DIHYDRO-SPIRO(3H-INDOLE-3-4 -PIPERIDINE) COMPOUNDS AS MODULATORS OF THE MAS RECEPTOR NOVEL | Arena Pharmaceuticals, Inc. (US) | 2008-03-19 | — | — | EP | claimed |
| WO-2007002114-A1 | 1,2-DIHYDRO-SPIRO(3H-INDOLE-3-4’-PIPERIDINE) COMPOUNDS AS MODULATORS OF THE MAS RECEPTOR NOVEL | ARENA PHARMACEUTICALS, INC. (US) | 2007-01-04 | — | — | WO | claimed |
| EP-1653960-A2 | MELANIN CONCENTRATING HORMONE RECEPTOR ANTAGONIST | AMGEN INC. (US) | 2006-05-10 | — | — | EP | claimed |
| US-20050215526-A1 | Melanin concentrating hormone receptor antagonist | AMGEN, INC. | 2005-09-29 | — | — | US | claimed |
| WO-2005019167-A2 | MELANIN CONCENTRATING HORMONE RECEPTOR ANTAGONIST | AMGEN, INC. (US) | 2005-03-03 | — | — | WO | claimed |
| WO-2024151706-A1 | FUNCTIONALIZATION OF SOLUBLE POLYDIENES AND POLYISOPRENES USING DITHIOPHOSPHORIC ACIDS | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2024-07-18 | — | — | WO | disclosed |
| US-20240194920-A1 | CARBENIUM BASED ORGANIC REDOX FLOW BATTERIES | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2024-06-13 | — | — | US | disclosed |
| US-20240085753-A1 | ELECTROCHROMIC COMPOSITION AND ELECTROCHROMIC DEVICE | TAI YING OPTRONICS CO., LTD. (TW) | 2024-03-14 | — | — | US | disclosed |
| US-11769905-B2 | Poly(alkylene oxide) siloxane-based electrolytes for rechargeable batteries | UCHICAGO ARGONNE, LLC (US) | 2023-09-26 | — | — | US | disclosed |
| WO-2023164025-A1 | REGENERATION OF SYMMETRICAL NONAQUEOUS ORGANIC REDOX FLOW BATTERIES | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2023-08-31 | — | — | WO | disclosed |
| EP-4178576-A1 | DEOXYNOJIRIMYCIN DERIVATIVES AS GLUCOSIDASE INHIBITORS | Emergent Product Development Gaithersburg Inc. (US) | 2023-05-17 | — | — | EP | disclosed |
| EP-4139981-A1 | CARBENIUM BASED ORGANIC REDOX FLOW BATTERIES | Arizona Board of Regents on behalf of The University of Arizona (US) | 2023-03-01 | — | — | EP | disclosed |
| CN-115298164-A | Process for preparing 4-cyanobenzoyl chlorides | 巴斯夫欧洲公司 | 2022-11-04 | — | — | CN | disclosed |
| WO-2022011211-A1 | DEOXYNOJIRIMYCIN DERIVATIVES AS GLUCOSIDASE INHIBITORS | EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. (US) | 2022-01-13 | — | — | WO | disclosed |
| WO-2021217092-A1 | CARBENIUM BASED ORGANIC REDOX FLOW BATTERIES | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2021-10-28 | — | — | WO | disclosed |
| EP-3215499-B1 | IMINOSUGARS USEFUL FOR THE TREATMENT OF VIRAL DISEASES | EMERGENT VIROLOGY LLC (US) | 2021-01-20 | — | — | EP | disclosed |
| US-20200384115-A1 | TARGETED DELIVERY TO BETA CELLS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2020-12-10 | — | — | US | disclosed |
| US-10840531-B2 | Two-electron redox active molecules with high capacity and energy density for energy storage applications | UCHICAGO ARGONNE, LLC (US) | 2020-11-17 | — | — | US | disclosed |
| EP-3612232-A1 | TARGETED DELIVERY TO BETA CELLS | The Broad Institute, Inc. (US) | 2020-02-26 | — | — | EP | disclosed |
| US-10428022-B2 | Iminosugars useful for the treatment of viral diseases | EMERGENT VIROLOGY LLC (US) | 2019-10-01 | — | — | US | disclosed |
| US-20190051921-A1 | TWO-ELECTRON REDOX CATHOLYTE FOR REDOX FLOW BATTERIES | UCHICAGO ARGONNE, LLC | 2019-02-14 | — | — | US | disclosed |
| US-20190044181-A1 | POLY(ALKYLENE OXIDE) SILOXANE-BASED ELECTROLYTES FOR RECHARGEABLE BATTERIES | UNITED STATES DEPARTMENT OF ENERGY | 2019-02-07 | — | — | US | disclosed |
| US-20180354991-A1 | THERAPEUTIC COMPOSITIONS INCLUDING GRAMICIDIN S PEPTIDYL CONJUGATES OR IMIDAZOLE-SUBSTITUTED FATTY ACIDS, VARIANTS THEREOF AND USES THEREOF | STEALTH PEPTIDES INTERNATIONAL, INC. (MC) | 2018-12-13 | — | — | US | disclosed |
| WO-2018195486-A1 | TARGETED DELIVERY TO BETA CELLS | THE BROAD INSTITUTE, INC. (US) | 2018-10-25 | — | — | WO | disclosed |
| US-20180273473-A1 | IMINOSUGARS USEFUL FOR THE TREATMENT OF VIRAL DISEASES | EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. | 2018-09-27 | — | — | US | disclosed |
| CN-108431092-A | The continuation method reacted with particle alkali metal dispersion | CHT R.拜特利希有限公司 | 2018-08-21 | — | — | CN | disclosed |
| US-10026984-B2 | Multi-electron redox active molecules for energy storage applications | UCHICAGO ARGONNE, LLC (US) | 2018-07-17 | — | — | US | disclosed |
| CN-105777482-B | A kind of 1-（1- chloromethyl vinyl bases）The synthetic method of -2,4- difluorobenzene | 浙江大学宁波理工学院 | 2018-06-15 | — | — | CN | disclosed |
| US-9991542-B2 | Two-electron high potential and high capacity redox active molecules for energy storage applications | UCHICAGO ARGONNE, LLC (US) | 2018-06-05 | — | — | US | disclosed |
| US-20180042983-A1 | THERAPEUTIC COMPOSITIONS INCLUDING MITOCHONDRIAL FISSION INHIBITOR PEPTIDES, VARIANTS THEREOF, AND METHODS OF USING THE SAME | STEALTH PEPTIDES INTERNATIONAL, INC. (MC) | 2018-02-15 | — | — | US | disclosed |
| EP-3256143-A2 | THERAPEUTIC COMPOSITIONS INCLUDING MITOCHONDRIAL FISSION INHIBITOR PEPTIDES, VARIANTS THEREOF AND METHODS OF USING THE SAME | Stealth Peptides International, Inc. (MC) | 2017-12-20 | — | — | EP | disclosed |
| EP-3215499-A1 | IMINOSUGARS USEFUL FOR THE TREATMENT OF VIRAL DISEASES | Emergent Virology LLC (US) | 2017-09-13 | — | — | EP | disclosed |
| CN-107022082-A | A kind of application of silicon substrate hyperbranched conjugated polymer in Nitro-aromatic Compounds in Different detection | 齐鲁工业大学 | 2017-08-08 | — | — | CN | disclosed |
| CN-107022083-A | A kind of silicon substrate hyperbranched conjugated polymer and preparation method thereof | 齐鲁工业大学 | 2017-08-08 | — | — | CN | disclosed |
| CN-106967076-A | One kind has 6H dibenzopyrans structural compounds and preparation method thereof | 河南师范大学 | 2017-07-21 | — | — | CN | disclosed |
| CN-104327200-B | The preparation method of polyalphaolefin | 埃克森美孚化学专利公司 | 2017-07-14 | — | — | CN | disclosed |
| CN-104211967-B | Polymetalcarbosilane, and preparation method and application thereof | 中国科学院过程工程研究所 | 2017-05-03 | — | — | CN | disclosed |
| US-20170062842-A1 | TWO-ELECTRON REDOX ACTIVE MOLECULES WITH HIGH CAPACITY AND ENERGY DENSITY FOR ENERGY STORAGE APPLICATIONS | UCHICAGO ARGONNE, LLC | 2017-03-02 | — | — | US | disclosed |
| US-20170062863-A1 | TWO-ELECTRON HIGH POTENTIAL AND HIGH CAPACITY REDOX ACTIVE MOLECULES FOR ENERGY STORAGE APPLICATIONS | UCHICAGO ARGONNE, LLC | 2017-03-02 | — | — | US | disclosed |
| US-20170062862-A1 | MULTI-ELECTRON REDOX ACTIVE MOLECULES FOR ENERGY STORAGE APPLICATIONS | UCHICAGO ARGONNE, LLC | 2017-03-02 | — | — | US | disclosed |
| WO-2016209261-A1 | THERAPEUTIC COMPOSITIONS INCLUDING GRAMICIDIN S PEPTIDYL CONJUGATES OR IMIDAZOLE-SUBSTITUTED FATTY ACIDS, VARIANTS THEREOF, AND USES THEREOF | STEALTH BIOTHERAPEUTICS CORP (MC) | 2016-12-29 | — | — | WO | disclosed |
| WO-2016200364-A1 | THERAPEUTIC COMPOSITIONS INCLUDING SkQ COMPOUNDS AND USES THEREOF | STEALTH PEPTIDES INTERNATIONAL, INC. (MC) | 2016-12-15 | — | — | WO | disclosed |
| WO-2016195663-A1 | THERAPEUTIC COMPOSITIONS INCLUDING BPM 31510, VARIANTS AND ANALOGUES THEREOF, AND USES THEREOF | STEALTH PEPTIDES INTERNATIONAL, INC. (MC) | 2016-12-08 | — | — | WO | disclosed |
| WO-2016190852-A1 | THERAPEUTIC COMPOSITIONS INCLUDING CHROMANYL COMPOUNDS, VARIANTS AND ANALOGUES THEREOF, AND USES THEREOF | STEALTH PEPTIDES INTERNATIONAL, INC. (MC) | 2016-12-01 | — | — | WO | disclosed |
| WO-2016130143-A2 | THERAPEUTIC COMPOSITIONS INCLUDING MITOCHONDRIAL FISSION INHIBITOR PEPTIDES, VARIANTS THEREOF AND METHODS OF USING THE SAME | STEALTH PEPTIDES INTERNATIONAL, INC. (MC) | 2016-08-18 | — | — | WO | disclosed |
| CN-105829294-A | METHYLENE LINKED QUINOLINYL MODULATORS OF ROR-GAMMA-T | 詹森药业有限公司 | 2016-08-03 | — | — | CN | disclosed |
| WO-2016073652-A1 | IMINOSUGARS USEFUL FOR THE TREATMENT OF VIRAL DISEASES | UNITHER VIROLOGY, LLC (US) | 2016-05-12 | — | — | WO | disclosed |
| EP-2415763-B1 | PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING GLAUCOMA | UBE INDUSTRIES (JP) | 2016-01-27 | — | — | EP | disclosed |
| WO-2016004093-A2 | THERAPEUTIC COMPOSITIONS INCLUDING GALECTIN-3 INHIBITORS AND USES THEREOF | STEALTH BIOTHERAPEUTICS CORP (MC) | 2016-01-07 | — | — | WO | disclosed |
| CN-102781884-B | Process for producing alpha-olefin oligomer | MITSUBISHI CHEMICAL CORP. (JP) | 2015-11-25 | — | — | CN | disclosed |
| CN-102448940-B | For the medical composition of glaucomatous treatment or prevention | UBE INDUSTRIES, LTD. (JP) | 2015-10-21 | — | — | CN | disclosed |
| CN-104926589-A | Process for producing alpha-olefin oligomer | MITSUBISHI CHEM CORP | 2015-09-23 | — | — | CN | disclosed |
| CN-103965099-A | Pyridylaminoacetic Acid Compound | UBE INDUSTRIES | 2014-08-06 | — | — | CN | disclosed |
| CN-101970410-B | Pyridylaminoacetic acid compounds | UBE INDUSTRIES | 2014-06-25 | — | — | CN | disclosed |
| US-20140113907-A1 | PYRIDYLAMINOACETIC ACID COMPOUND | UBE INDUSTRIES, LTD. (JP) | 2014-04-24 | — | — | US | disclosed |
| US-8648097-B2 | Pyridylaminoacetic acid compound | UBE INDUSTRIES, LTD. (JP) | 2014-02-11 | — | — | US | disclosed |
| CN-102781884-A | Process for producing alpha-olefin oligomer | MITSUBISHI CHEM CORP | 2012-11-14 | — | — | CN | disclosed |
| EP-2520570-A1 | AMINOPYRIDINE COMPOUND | Ube Industries, Ltd. (JP) | 2012-11-07 | — | — | EP | disclosed |
| US-20120259123-A1 | AMINOPYRIDINE COMPOUND | UBE INDUSTRIES, LTD. (JP) | 2012-10-11 | — | — | US | disclosed |
| CN-102666490-A | Aminopyridine compound | UBE INDUSTRIES | 2012-09-12 | — | — | CN | disclosed |
| US-20120190852-A1 | MEDICAL COMPOSITION FOR TREATMENT OR PROPHYLAXIS OF GLAUCOMA | UBE INDUSTRIES, LTD. (JP) | 2012-07-26 | — | — | US | disclosed |
| CN-102448940-A | Pharmaceutical composition for treating or preventing glaucoma | UBE INDUSTRIES | 2012-05-09 | — | — | CN | disclosed |
| US-8114886-B2 | Pyridylmethylsulfone derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2012-02-14 | — | — | US | disclosed |
| EP-2415763-A1 | PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING GLAUCOMA | Ube Industries, Ltd. (JP) | 2012-02-08 | — | — | EP | disclosed |
| CN-101107260-B | Transition metal complex, method for producing the same, substituted fluorene compound, method for producing the substituted fluorene compound, catalyst component for olefin polymerization, catalyst for olefin polymerization, and method for producing olefin polymer | SUMITOMO CHEMICAL CO.,LTD. (JP) | 2012-02-08 | — | — | CN | disclosed |
| CN-101163678-B | Pyridylmethylsulfone derivative | DAIICHI SANKYO CO LTD | 2012-01-04 | — | — | CN | disclosed |
| US-20110054172-A1 | PYRIDYLAMINOACETIC ACID COMPOUND | UBE CORPORATION (JP) | 2011-03-03 | — | — | US | disclosed |
| CN-101970410-A | Pyridylaminoacetic acid compounds | UBE INDUSTRIES | 2011-02-09 | — | — | CN | disclosed |
| EP-2264009-A1 | PYRIDYLAMINOACETIC ACID COMPOUND | Ube Industries, Ltd. (JP) | 2010-12-22 | — | — | EP | disclosed |
| US-20100222330-A1 | New Compounds | BIOVITRUM AB (SE) | 2010-09-02 | — | — | US | disclosed |
| US-7659276-B2 | Melanin concentrating hormone receptor antagonist | AMGEN, INC. (US) | 2010-02-09 | — | — | US | disclosed |
| CN-100584462-C | Bimetallic catalyst with high activity | EXXONMOBIL CHEMICAL PATENT CO | 2010-01-27 | — | — | CN | disclosed |
| US-7572787-B2 | Substituted naphthalene sulfonamides | BIOVITRUM AB (SE) | 2009-08-11 | — | — | US | disclosed |
| US-20090149439-A1 | PYRIDYLMETHYSULFONE DERIVATIVE | DAIICHI SANKYO COMPANY LIMITED (JP) | 2009-06-11 | — | — | US | disclosed |
| US-20090143405-A1 | MELANIN CONCENTRATING HORMONE RECEPTOR ANTAGONIST | AMGEN, INC. (US) | 2009-06-04 | — | — | US | disclosed |
| CN-101402601-A | Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes | BIOVITRUM AB PUBL (SE) | 2009-04-08 | — | — | CN | disclosed |
| US-7514438-B2 | Melanin concentrating hormone receptor antagonist | AMGEN, INC. (US) | 2009-04-07 | — | — | US | disclosed |
| CN-100457726-C | Substituted sulfonamide compounds, process for their preparation and their use as medicaments for the treatment of CNS disorders, obesity and type II diabetes | CAMBRIDGE BIOTECHNOLOGY LTD (SE) | 2009-02-04 | — | — | CN | disclosed |
| EP-1653960-A4 | MELANIN CONCENTRATING HORMONE RECEPTOR ANTAGONIST | AMGEN INC (US) | 2008-11-26 | — | — | EP | disclosed |
| EP-1675830-A4 | HETEROCYCLIC AMIDES AND SULFONAMIDES | SCIOS INC (US) | 2008-08-20 | — | — | EP | disclosed |
| CN-101163678-A | Pyridylmethylsulfone derivative | DAIICHI SANKYO CO LTD (JP) | 2008-04-16 | — | — | CN | disclosed |
| CN-100371351-C | Organometal catalyst compositions | PHILLIPS PETROLEUM CO (US) | 2008-02-27 | — | — | CN | disclosed |
| CN-101107260-A | Transition metal complex, method for producing the same, substituted fluorene compound, method for producing the substituted fluorene compound, catalyst component for olefin polymerization, catalyst for olefin polymerization, and method for producing olefin polymer | SUMITOMO CHEMICAL CO (JP) | 2008-01-16 | — | — | CN | disclosed |
| EP-1867636-A1 | PYRIDYLMETHYLSULFONE DERIVATIVE | Daiichi Sankyo Company, Limited (JP) | 2007-12-19 | — | — | EP | disclosed |
| CN-101062959-A | Method of making mixed ziegler-natta/metallocece catalysts | EXXONMOBIL CHEM PATENTS INC (US) | 2007-10-31 | — | — | CN | disclosed |
| US-7276511-B2 | Benzylamine derivative | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 2007-10-02 | — | — | US | disclosed |
| CN-1319995-C | Reactor wall coating and method of forming the same | UNIVATION TECH LLC (US) | 2007-06-06 | — | — | CN | disclosed |
| US-20070066598-A1 | Compounds | BIOVITRUM AB, A SWEDEN CORPORATION | 2007-03-22 | — | — | US | disclosed |
| US-20070066599-A1 | New compounds | BIOVITRUM AB, A SWEDEN CORPORATION | 2007-03-22 | — | — | US | disclosed |
| US-20070066600-A1 | Compounds | PROXIMAGEN NEUROSCIENCE PLC (GB) | 2007-03-22 | — | — | US | disclosed |
| CN-1301190-C | Laminated film | JAPAN POLYCHEM CORP (JP) | 2007-02-21 | — | — | CN | disclosed |
| US-7144883-B2 | Bicyclic sulfonamide compounds | BIOVITRUM AB (SE) | 2006-12-05 | — | — | US | disclosed |
| CN-1868583-A | Organometal catalyst compositions | PHILLIPS PETROLEUM CO (US) | 2006-11-29 | — | — | CN | disclosed |
| US-20060199821-A1 | Heterocyclic amides and sulfonamides | SCIOS, INC. (US) | 2006-09-07 | — | — | US | disclosed |
| CN-1829689-A | Phenylmethylamine derivatives | ZERIA PHARM CO LTD (JP) | 2006-09-06 | — | — | CN | disclosed |
| US-20060194841-A1 | E.g., N-{2-(3,4-dichlorophenyl)-2-[(3,3-diphenylpropionyl)-methylamino]-4-{spiro[benzo(c)thiophene-1(3H),4'-piperidine]-(2S)-oxide}-1'-yl-butyl}-3,3,3-trifluoro-N-methyl-propionamide hydrochloride, NK-1 or NK-2 receptor antagonists; irritable bowel syndrome, pain, anxiety, COPD, headaches and vomiting | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 2006-08-31 | — | — | US | disclosed |
| CN-1267191-C | organometallic catalyst composition | PHILLIPS PETROLEUM CO (US) | 2006-08-02 | — | — | CN | disclosed |
| US-7084137-B2 | Thiazines and thiazoles as agents for protecting materials | BAYER AKTIENGESELLSCHAFT (DE) | 2006-08-01 | — | — | US | disclosed |
| CN-1800185-A | Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes. | BIOVITRUM AB (SE) | 2006-07-12 | — | — | CN | disclosed |
| EP-1675830-A2 | HETEROCYCLIC AMIDES AND SULFONAMIDES | SCIOS INC. (US) | 2006-07-05 | — | — | EP | disclosed |
| EP-1653960-A2 | MELANIN CONCENTRATING HORMONE RECEPTOR ANTAGONIST | AMGEN INC. (US) | 2006-05-10 | — | — | EP | disclosed |
| EP-1650189-A1 | BENZYLAMINE DERIVATIVE | Zeria Pharmaceutical Co., Ltd. (JP) | 2006-04-26 | — | — | EP | disclosed |
| CN-1231294-C | Organic metal catalyst composition | PHILLIPS PETROLEUM CO (US) | 2005-12-14 | — | — | CN | disclosed |
| CN-1691979-A | Bimetallic catalysts with higher activity | EXXONMOBIL CHEM PATENTS INC (US) | 2005-11-02 | — | — | CN | disclosed |
| CN-1688608-A | Reactor wall coating and processes for forming same | UNIVATION TECH LLC (US) | 2005-10-26 | — | — | CN | disclosed |
| US-20050215526-A1 | Melanin concentrating hormone receptor antagonist | AMGEN, INC. | 2005-09-29 | — | — | US | disclosed |
| CN-1625440-A | Bimetallic catalyst with high activity | EXXONMOBIL CHEMICAL PATENT CO (US) | 2005-06-08 | — | — | CN | disclosed |
| CN-1202138-C | Organometal catalyst compositions | PHILLIPS PETROLEUM CO (US) | 2005-05-18 | — | — | CN | disclosed |
| WO-2005033072-A2 | HETEROCYCLIC AMIDES AND SULFONAMIDES | SCIOS INC. (US) | 2005-04-14 | — | — | WO | disclosed |
| WO-2005019167-A2 | MELANIN CONCENTRATING HORMONE RECEPTOR ANTAGONIST | AMGEN, INC. (US) | 2005-03-03 | — | — | WO | disclosed |
| CN-1188431-C | Organometal compound catalyst | PHILLIPS PETROLEUM CO (US) | 2005-02-09 | — | — | CN | disclosed |
| CN-1558826-A | Laminated film | 日本聚丙烯公司 | 2004-12-29 | — | — | CN | disclosed |
| US-20040204405-A1 | Thiazines and thiazoles as agents for protecting materials | LANXESS DEUTSCHLAND GMBH (DE) | 2004-10-14 | — | — | US | disclosed |
| CN-1522245-A | Substituted sulfonamide compounds, process for their preparation and their use as medicaments for the treatment of CNS disorders, obesity and type II diabetes | �Ȱ�ά����ķ�ɷݹ�˾ | 2004-08-18 | — | — | CN | disclosed |
| EP-1437940-A1 | THIAZINES AND THIAZOLES FOR USE AS MATERIAL PROTECTIVE AGENTS | Bayer Chemicals AG (DE) | 2004-07-21 | — | — | EP | disclosed |
| EP-1412325-A1 | SUBSTITUTED SULFONAMIDE COMPOUNDS, PROCESS FOR THEIR USE AS MEDICAMENT FOR THE TREATMENT OF CNS DISORDERS, OBESITY AND TYPE II DIABETES | BIOVITRUM AB (SE) | 2004-04-28 | — | — | EP | disclosed |
| CN-1137902-C | Supported polymerization catalysts | — | 2004-02-11 | — | — | CN | disclosed |
| CN-1128168-C | Process for preparing polyolefin compositions | MITSUI CHEMICALS INC (JP) | 2003-11-19 | — | — | CN | disclosed |
| US-20030158202-A1 | Substituted fused ring sulfonamides containing, e.g., naphthalene, isoquinoline, quinoline, benzofuran or benzothiophene rings; treatment of conditions relating to obesity, type II diabetes and CNS disorders | PROXIMAGEN NEUROSCIENCE PLC (GB) | 2003-08-21 | — | — | US | disclosed |
| US-20030129081-A1 | Thiazines and thiazoles as agents for protecting materials | BAYER AKTIENGESELLSCHAFT (DE) | 2003-07-10 | — | — | US | disclosed |
| CN-1110366-C | Non-pyrophoric solids | BASF AG (DE) | 2003-06-04 | — | — | CN | disclosed |
| CN-1414978-A | Organometal catalyst compositions | PHILLIPS PETROLEUM CO (US) | 2003-04-30 | — | — | CN | disclosed |
| CN-1414880-A | Organometal compound catalyst | PHILLIPS PETROLEUM CO (US) | 2003-04-30 | — | — | CN | disclosed |
| CN-1404491-A | Process for producing polyolefin composition | MITSUI CHEMICALS INC (JP) | 2003-03-19 | — | — | CN | disclosed |
| WO-2003001913-A1 | THIAZINES AND THIAZOLES FOR USE AS MATERIAL PROTECTIVE AGENTS | BAYER CHEMICALS AG (DE) | 2003-01-09 | — | — | WO | disclosed |
| WO-2002100822-A1 | SUBSTITUTED SULFONAMIDE COMPOUNDS, PROCESS FOR THEIR USE AS MEDICAMENT FOR THE TREATMENT OF CNS DISORDERS, OBESITY AND TYPE II DIABETES | BIOVITRUM AB (SE) | 2002-12-19 | — | — | WO | disclosed |
| CN-1377373-A | organometallic catalyst composition | PHILLIPS PETROLEUM CO (US) | 2002-10-30 | — | — | CN | disclosed |
| CN-1376167-A | organometallic catalyst composition | PHILLIOPS PETROLEUM COMPANY (US) | 2002-10-23 | — | — | CN | disclosed |
| CN-1092659-C | Novel pyrimidine derivative | OTSUKA PHARMA CO LTD (JP) | 2002-10-16 | — | — | CN | disclosed |
| CN-1373373-A | Oblique raster type light isolator and its preparing process | HAO MING (CN) | 2002-10-09 | — | — | CN | disclosed |
| CN-1323319-A | Supported polymerization catalysts | BOREALIS AS (FI) | 2001-11-21 | — | — | CN | disclosed |
| CN-1070487-C | Hexahydronaphthalene ester derivatives, their preparation and their therapeutic uses | SANKYO CO (JP) | 2001-09-05 | — | — | CN | disclosed |
| CN-1304800-A | Organic metal catalyst composition | PHILLIPS PETROLEUM CO (US) | 2001-07-25 | — | — | CN | disclosed |
| CN-1301600-A | organometallic catalyst composition | PHILLIPS PETROLEUM CO (US) | 2001-07-04 | — | — | CN | disclosed |
| US-6242449-B1 | TREATING PROSTATIC HYPERTROPHY, URINATION DISORDERS ASSOCIATED WITH PROSTATIC HYPERTROPHY, MALE PATTERN ALOPECIA, OR ACNE | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 2001-06-05 | — | — | US | disclosed |
| CN-1292007-A | Method for making polymer blends by using series reactors | EXXON CHEMICAL PATENTS INC (US) | 2001-04-18 | — | — | CN | disclosed |
| US-6197774-B1 | THERAPY FOR ASTHMA, SKIN DISORDERS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2001-03-06 | — | — | US | disclosed |
| CN-1264365-A | 3-benzoylindole derivatives and drugs containing the same | ZERIA PHARM CO LTD (JP) | 2000-08-23 | — | — | CN | disclosed |
| EP-1019501-A1 | NOVEL PYRIMIDINE DERIVATIVE | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2000-07-19 | — | — | EP | disclosed |
| CN-1052734-C | Propylene elastomer | MITSUI PETROCHEMICAL IND (JP) | 2000-05-24 | — | — | CN | disclosed |
| EP-0997457-A1 | 3-BENZOYLINDOLE DERIVATIVES AND DRUGS CONTAINING THE SAME | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 2000-05-03 | — | — | EP | disclosed |
| CN-1251057-A | Non self-igniting solid | BASF AG (DE) | 2000-04-19 | — | — | CN | disclosed |
| CN-1250450-A | Novel pyrimidine derivative | OTSUKA PHARMA CO LTD (JP) | 2000-04-12 | — | — | CN | disclosed |
| CN-1048733-C | Prepolymerized catalyst, catalyst for olefin polymerization, polymerization process of olefin, and olefin polymer | MITSUI PETROCHEMICAL IND (JP) | 2000-01-26 | — | — | CN | disclosed |
| CN-1043144-C | Prepolymerized catalyst, catalyst for olefin polymerization, and process for olefin polymerization | MITSUI CHEMICALS INC (JP) | 1999-04-28 | — | — | CN | disclosed |
| EP-0765351-B1 | AMIDATION OF ESTER FUNCTIONALIZED HYDROCARBON POLYMERS | EXXON CHEMICAL PATENTS INC (US) | 1999-01-13 | — | — | EP | disclosed |
| WO-1998041526-A1 | NOVEL PYRIMIDINE DERIVATIVE | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1998-09-24 | — | — | WO | disclosed |
| US-5627259-A | REACTION OF OLEFIN POLYMERS WITH CARBON MONOXIDE AND ALCOHOL THEN REACTION OF ESTER WITH POLYAMINE COMPOUND RELEASING ALCOHOL COMPOUND | EXXON CHEMICAL PATENTS INC. (US) | 1997-05-06 | — | — | US | disclosed |
| EP-0765351-A1 | AMIDATION OF ESTER FUNCTIONALIZED HYDROCARBON POLYMERS | EXXON CHEMICAL PATENTS INC. (US) | 1997-04-02 | — | — | EP | disclosed |
| WO-1995035330-A1 | AMIDATION OF ESTER FUNCTIONALIZED HYDROCARBON POLYMERS | EXXON CHEMICAL PATENTS INC. (US) | 1995-12-28 | — | — | WO | disclosed |
| CN-1113494-A | Prepolymerized catalyst, catalyst for olefin polymerization, polymerization process of olefin, and olefin polymer | MITSUI PETROCHEMICAL IND (JP) | 1995-12-20 | — | — | CN | disclosed |
| CN-1029405-C | Lipid A analogs having immunoactivating and anti-tumor activity | SANKYO CO (JP) | 1995-08-02 | — | — | CN | disclosed |
| EP-0282895-B1 | 2-oxa-isocephem compounds, compositions containing same and processes for preparing same | OTSUKA PHARMA CO LTD (JP) | 1995-06-07 | — | — | EP | disclosed |
| CN-1091432-A | Can suppress the active peptide of hiv protease, its preparation with and medical use | SANKYO CO (JP) | 1994-08-31 | — | — | CN | disclosed |
| CN-1091128-A | Piperidine derivative | SANKYO CO (JP) | 1994-08-24 | — | — | CN | disclosed |
| CN-1023801-C | 2-Oxa-isocephem compounds, compositions containing same and processes for preparing same | OTSUKA PHARMA CO LTD (JP) | 1994-02-16 | — | — | CN | disclosed |
| CN-1070651-A | Catalyst for olefin polymerization and olefin polymer | MITSUI PETROCHEMICAL IND (JP) | 1993-04-07 | — | — | CN | disclosed |
| EP-0320733-B1 | 2-TERT.-BUTYL-5-ISOXAZOLYL METHYLTHIO-3(2H)-PYRIDAZIN-3-ONE DERIVATIVES | BASF Aktiengesellschaft (DE) | 1993-03-03 | — | — | EP | disclosed |
| US-5126461-A | Silica in organic solution | SHELL RESEARCH LIMITED (GB) | 1992-06-30 | — | — | US | disclosed |
| US-5037976-A | Antimicrobial Agent | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1991-08-06 | — | — | US | disclosed |
| EP-0437016-A2 | Lipid A analogues having immunoactivating and anti-tumour activity | Sankyo Company Limited (JP) | 1991-07-17 | — | — | EP | disclosed |
| EP-0243173-B1 | NEW DIPHOSPHONIC ACID COMPOUNDS, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1991-06-26 | — | — | EP | disclosed |
| CN-1052481-A | Lipoid category-A with immunocompetence and anti-tumor activity is like thing | SANKYO CO (JP) | 1991-06-26 | — | — | CN | disclosed |
| EP-0432818-A2 | Process for opening cyclopropane rings | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1991-06-19 | — | — | EP | disclosed |
| US-4963530-A | Renin inhibitor peptide compounds, a process for the preparation thereof and pharmaceutical composition comprising the same | FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) | 1990-10-16 | — | — | US | disclosed |
| US-4963536-A | INHIBIT BONE RESORPTION | FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) | 1990-10-16 | — | — | US | disclosed |
| US-4929617-A | INSECTICIDES, MITICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1990-05-29 | — | — | US | disclosed |
| US-4898859-A | 2-Oxa-isocephem compounds and compositions containing same | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1990-02-06 | — | — | US | disclosed |
| EP-0351589-A2 | 3(2H)-Pyridazinone derivatives for controlling snails | BASF Aktiengesellschaft (DE) | 1990-01-24 | — | — | EP | disclosed |
| US-4857513-A | Diphosphonic acid compounds, processes for the preparation thereof and pharmaceutical composition comprising the same | FUJISIWA PHARMACEUTICAL CO., LTD. (JP) | 1989-08-15 | — | — | US | disclosed |
| EP-0320733-A2 | 2-tert.-butyl-5-isoxazolyl methylthio-3(2H)-pyridazin-3-one derivatives | BASF Aktiengesellschaft (DE) | 1989-06-21 | — | — | EP | disclosed |
| CN-88102161-A | 2-oxa-isocephem compounds, compositions containing them and processes for their preparation | — | 1988-10-05 | — | — | CN | disclosed |
| EP-0283970-A2 | New peptide compounds, a process for the preparation thereof and pharmaceutical composition comprising the same | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1988-09-28 | — | — | EP | disclosed |
| EP-0282895-A2 | 2-oxa-isocephem compounds, compositions containing same and processes for preparing same | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1988-09-21 | — | — | EP | disclosed |
| EP-0243173-A2 | New diphosphonic acid compounds, processes for the preparation thereof and pharmaceutical composition comprising the same | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1987-10-28 | — | — | EP | disclosed |
| US-4488897-A | Dichloromethyl oxadiazole herbicide antidotes | STAUFFER CHEMICAL COMPANY (US) | 1984-12-18 | — | — | US | disclosed |
| US-4488897-A | Dichloromethyl oxadiazole herbicide antidotes | STAUFFER CHEMICAL COMPANY (US) | 1984-12-18 | — | — | US | disclosed |
| US-RE29577-E | Anthraquinone dyestuffs | BAYER AKTIENGESELLSCHAFT (DT) | 1978-03-14 | — | — | US | disclosed |
| US-3963763-A | Anthraquinone dyestuffs | BAYER AKTIENGESELLSCHAFT (DT) | 1976-06-15 | — | — | US | disclosed |
| US-3963763-A | Anthraquinone dyestuffs | BAYER AKTIENGESELLSCHAFT (DT) | 1976-06-15 | — | — | US | disclosed |